PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
29-Oct-2025 Creative BioMart Launches Enhanced Protein Phylogenetic Analysis Service to Deepen Evolutionary Insight Creative BioMart
29-Oct-2025 Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025 ACCESS Newswire
29-Oct-2025 Spago Nanomedical Resolves on a Rights Issue of Approximately SEK 25 million to Advance Tumorad ACCESS Newswire
29-Oct-2025 Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability ACCESS Newswire
29-Oct-2025 Spago Nanomedical Interim Report January-September 2025 ACCESS Newswire
29-Oct-2025 BioInvent International AB: Interim Report January - September 2025 ACCESS Newswire
29-Oct-2025 Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards ACCESS Newswire
29-Oct-2025 IRLAB Publishes Interim Report for The Period January - September 2025 ACCESS Newswire
29-Oct-2025 Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 ACCESS Newswire
28-Oct-2025 Prepare for 340B's Rebate Model Pilot Program ACCESS Newswire
28-Oct-2025 Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series ACCESS Newswire
28-Oct-2025 Beauty-Stem's "Beauty Beyond Age" Forum ACCESS Newswire
28-Oct-2025 Crushed No More? Whole Tablets Safe in Stroke Dysphagia Karl Landsteiner University (KL Krems)
28-Oct-2025 Symbiosis Builds Global Business Development Strength with Two North American Appointments Symbiosis
28-Oct-2025 Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) ACCESS Newswire
28-Oct-2025 Tricuspid Valve Repair Market Research, Size, Share and Trends, Growth Forecast to 2028 Medi-Tech Insights
28-Oct-2025 NICE recommends Bayer’s Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option for patients with hormone-sensitive metastatic prostate cancer Bayer
28-Oct-2025 Who is Javad Sajan? ACCESS Newswire
28-Oct-2025 ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices ViiV Healthcare
28-Oct-2025 Publication of Landmark Study in JACC: Advances ACCESS Newswire